These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34188210)

  • 81. Role of Ancillary Testing on Endoscopic US-Guided Fine Needle Aspiration Samples from Cystic Pancreatic Neoplasms.
    Jhala N; Srimunta P; Jhala D
    Acta Cytol; 2020; 64(1-2):124-135. PubMed ID: 31509835
    [TBL] [Abstract][Full Text] [Related]  

  • 82. C-myc deregulation in pancreatic carcinomas.
    Petrogiannopoulos L; Niotis A; Niotis T; Tsiambas E
    J BUON; 2019; 24(6):2578. PubMed ID: 31983137
    [No Abstract]   [Full Text] [Related]  

  • 83. Cancer gene profiling in pancreatic cancer.
    Vilardell F; Iacobuzio-Donahue CA
    Methods Mol Biol; 2010; 576():279-92. PubMed ID: 19882267
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Organoid models for translational pancreatic cancer research.
    Tiriac H; Plenker D; Baker LA; Tuveson DA
    Curr Opin Genet Dev; 2019 Feb; 54():7-11. PubMed ID: 30844513
    [TBL] [Abstract][Full Text] [Related]  

  • 85. DNA Repair Dysfunction in Pancreatic Cancer: A Clinically Relevant Subtype for Drug Development.
    Golan T; Javle M
    J Natl Compr Canc Netw; 2017 Aug; 15(8):1063-1069. PubMed ID: 28784866
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The role of miR-21 and miR-211 on MMP9 regulation in pancreatic ductal adenocarcinoma: cooperation in invasiveness behaviors?
    Funel N
    Epigenomics; 2015; 7(3):333-5. PubMed ID: 26077422
    [No Abstract]   [Full Text] [Related]  

  • 87. Molecular pathogenesis of pancreatic ductal adenocarcinoma and clinical implications.
    Magee CJ; Greenhalf W; Howes N; Ghaneh P; Neoptolemos JP
    Surg Oncol; 2001; 10(1-2):1-23. PubMed ID: 11719025
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Precursors of pancreatic cancer.
    Frič P; Škrha J; Šedo A; Bušek P; Laclav M; Bunganič B; Zavoral M
    Eur J Gastroenterol Hepatol; 2017 Mar; 29(3):e13-e18. PubMed ID: 28009716
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Does the Cytogenetic Analysis Using Fluorescence
    Kim DU
    Gut Liver; 2020 Jul; 14(4):397-398. PubMed ID: 32655017
    [No Abstract]   [Full Text] [Related]  

  • 90. Implementation of a Video-based Remote Germline Testing for Individuals With Pancreatic Ductal Adenocarcinoma.
    Kasliwal S; Baydogan S; Harrison D; Mork M; Maitra A; Mcallister F
    Gastroenterology; 2022 Jul; 163(1):316-318.e1. PubMed ID: 35339459
    [No Abstract]   [Full Text] [Related]  

  • 91. Pancreatic cancer genomes: toward molecular subtyping and novel approaches to diagnosis and therapy.
    Wood LD
    Mol Diagn Ther; 2013 Oct; 17(5):287-97. PubMed ID: 23757204
    [TBL] [Abstract][Full Text] [Related]  

  • 92. A metabolic vulnerability of pancreatic cancer.
    Puleston DJ
    Nature; 2023 Apr; 616(7956):257-258. PubMed ID: 36991046
    [No Abstract]   [Full Text] [Related]  

  • 93. Pancreatic Cancer: A Review.
    Park W; Chawla A; O'Reilly EM
    JAMA; 2021 Sep; 326(9):851-862. PubMed ID: 34547082
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Cancer statistics, 2022.
    Siegel RL; Miller KD; Fuchs HE; Jemal A
    CA Cancer J Clin; 2022 Jan; 72(1):7-33. PubMed ID: 35020204
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Analysis of cuproptosis-related lncRNA signature for predicting prognosis and tumor immune microenvironment in pancreatic cancer.
    Yao HF; Xu DP; Zheng JH; Xu Y; Jia QY; Zhu YH; Yang J; He RZ; Ma D; Yang MW; Fu XL; Liu DJ; Huo YM; Yang JY; Zhang JF
    Apoptosis; 2023 Aug; 28(7-8):1090-1112. PubMed ID: 37079192
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Copper induces cell death by targeting lipoylated TCA cycle proteins.
    Tsvetkov P; Coy S; Petrova B; Dreishpoon M; Verma A; Abdusamad M; Rossen J; Joesch-Cohen L; Humeidi R; Spangler RD; Eaton JK; Frenkel E; Kocak M; Corsello SM; Lutsenko S; Kanarek N; Santagata S; Golub TR
    Science; 2022 Mar; 375(6586):1254-1261. PubMed ID: 35298263
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Systemic Analyses of Cuproptosis-Related lncRNAs in Pancreatic Adenocarcinoma, with a Focus on the Molecular Mechanism of LINC00853.
    Chen L; Zhang L; He H; Shao F; Gao Y; He J
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175629
    [TBL] [Abstract][Full Text] [Related]  

  • 98. A novel cuproptosis-related lncRNA signature predicts the prognosis and immune landscape in bladder cancer.
    Bai Y; Zhang Q; Liu F; Quan J
    Front Immunol; 2022; 13():1027449. PubMed ID: 36451815
    [TBL] [Abstract][Full Text] [Related]  

  • 99. A comprehensive review of pancreatic cancer and its therapeutic challenges.
    Jiang S; Fagman JB; Ma Y; Liu J; Vihav C; Engstrom C; Liu B; Chen C
    Aging (Albany NY); 2022 Sep; 14(18):7635-7649. PubMed ID: 36173644
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Risk factors for acute pancreatitis post percutaneous transhepatic biliary stenting in patients with distal malignant obstruction.
    Zhang C; Liu Y; Zhou X; Sun Z; Li Y; Hou R; Han X; Jiao D
    Quant Imaging Med Surg; 2024 Sep; 14(9):6508-6516. PubMed ID: 39281182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.